Development of medicines to treat tuberculosis

1 August 2016 - Comments on draft guidance invited until 31 January 2017.

The EMA has launched a public consultation on revised guidance on the development of new medicines to treat tuberculosis (TB). The guidance is an addendum to EMA’s guideline on the evaluation of medicines to treat bacterial infections.

Stakeholders can send their comments to the Agency until 31 January 2017.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder